113 related articles for article (PubMed ID: 354301)
1. Factors affecting the beta-cell sensitivity to alloxan in vivo. Influence of pre- and post-treatment with protective substances.
Boquist L
Acta Endocrinol (Copenh); 1978 Jul; 88(3):556-61. PubMed ID: 354301
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic B-cell sensitivity to alloxan in vivo. A study of antagonizing compounds, serum inorganic phosphate and acid-base balance.
Boquist L
Acta Pathol Microbiol Scand A; 1978 Jul; 86(4):313-8. PubMed ID: 362804
[TBL] [Abstract][Full Text] [Related]
3. Effect of metabolic alkalosis on the B-cell sensitivity to alloxan in vivo.
Boquist L
Horm Metab Res; 1978 Nov; 10(6):477-81. PubMed ID: 33888
[TBL] [Abstract][Full Text] [Related]
4. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
[TBL] [Abstract][Full Text] [Related]
5. Alloxan diabetogenicity: determinants of potentiation, protection and B-cell selectivity.
Boquist L
Diabete Metab; 1989; 15(1):23-9. PubMed ID: 2542107
[TBL] [Abstract][Full Text] [Related]
6. Effects of alloxan on the islets of Langerhans. Possible mechanisms of diabetogenic action.
Borg LA
Acta Biol Med Ger; 1981; 40(1):71-6. PubMed ID: 7020307
[TBL] [Abstract][Full Text] [Related]
7. Reduction in the diabetogenic effect of alloxan in mice by treatment with the antineoplastic agent ICRF-187.
El-Hage AN; Herman EH; Ferrans VJ
Res Commun Chem Pathol Pharmacol; 1981 Sep; 33(3):509-23. PubMed ID: 7036302
[TBL] [Abstract][Full Text] [Related]
8. Studies on streptozotocin diabetes.
Ganda OP; Rossini AA; Like AA
Diabetes; 1976 Jul; 25(7):595-603. PubMed ID: 132382
[TBL] [Abstract][Full Text] [Related]
9. Tilapia islet grafts are highly alloxan-resistant.
Xu BY; Morrison CM; Yang H; Wright JR
Gen Comp Endocrinol; 2004 Jun; 137(2):132-40. PubMed ID: 15158125
[TBL] [Abstract][Full Text] [Related]
10. Alloxan-glucose interaction: effect on incorporation of 14C-leucine into pancreatic islets of rat.
Bansal R; Ahmad N; Kidwai JR
Acta Diabetol Lat; 1980; 17(2):135-43. PubMed ID: 7004041
[TBL] [Abstract][Full Text] [Related]
11. Differences in the blood glucose response of mice to alloxan and alloxan-inhibiting compounds.
Boquist L
Acta Endocrinol (Copenh); 1979 Dec; 92(4):687-93. PubMed ID: 532524
[No Abstract] [Full Text] [Related]
12. The endocrine pancreas in early alloxan diabetes. Including study of the alloxan inhibitory effect of feeding and some hexoses.
Boquist L
Acta Pathol Microbiol Scand A; 1977 Mar; 85A(2):219-29. PubMed ID: 322443
[TBL] [Abstract][Full Text] [Related]
13. [Protective effect of verapamil against alloxan-induced damage on pancreatic islet beta-cells in rats].
Wei YJ; Yu GZ; Zhang GF; Yu JR
Sheng Li Xue Bao; 1992 Apr; 44(2):209-14. PubMed ID: 1621112
[TBL] [Abstract][Full Text] [Related]
14. p-Hydroxymercuribenzoate-induced hyperglycemia: influence of pre- and post-treatment with L-leucine, tolbutamide, D-mannoheptulose, insulin and alloxan.
Boquist L
J Endocrinol Invest; 1979; 2(4):413-7. PubMed ID: 395187
[TBL] [Abstract][Full Text] [Related]
15. Effect of alloxan on insulin secretion in isolated rat islets perifused in vitro.
Tomita T; Lacy PE; Natschinsky FM; McDaniel ML
Diabetes; 1974 Jun; 23(6):517-24. PubMed ID: 4600579
[No Abstract] [Full Text] [Related]
16. Influence of alloxan administration on the blood glucose, islets of langerhans and some other tissues of the frog, Rana tigrina.
Kumar S; Khanna SS
Anat Anz; 1978; 143(3):242-9. PubMed ID: 356673
[TBL] [Abstract][Full Text] [Related]
17. On the mechanism of glucose protection against alloxan toxicity.
Scheynius A; Täljedal IB
Diabetologia; 1971 Aug; 7(4):252-5. PubMed ID: 4937446
[No Abstract] [Full Text] [Related]
18. Effects of alloxan on electric activity of mouse pancreatic B cells in vitro.
Shen XM; Su QF; Qian ZW; Zhang JR
Zhongguo Yao Li Xue Bao; 1994 Sep; 15(5):439-42. PubMed ID: 7717071
[TBL] [Abstract][Full Text] [Related]
19. The protective effect of glucose, but not 3-O-methyl glucose, against alloxan-induced diabetes depends upon the route of hexose administration.
Jansson L; Sandler S
Arch Int Pharmacodyn Ther; 1988; 293():257-64. PubMed ID: 3048222
[TBL] [Abstract][Full Text] [Related]
20. Physiological and morphological changes in islet B cells following treatment of the guinea pig with alloxan.
Gorray KC; Baskin DG; Fujimoto WY
Diabetes Res; 1986 May; 3(4):187-91. PubMed ID: 3527515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
